avapro has been researched along with Hyperpotassemia in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, FY | 1 |
| Lin, FJ | 1 |
| Ou, HT | 1 |
| Huang, SH | 1 |
| Wang, CC | 1 |
| Ito, S | 1 |
| Bonvini, RF | 1 |
| Hendiri, T | 1 |
| Anwar, A | 1 |
| Walser, M | 1 |
1 review available for avapro and Hyperpotassemia
| Article | Year |
|---|---|
[Antihypertensive therapy in renal dysfunction].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; | 2003 |
3 other studies available for avapro and Hyperpotassemia
| Article | Year |
|---|---|
Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds | 2017 |
Sinus arrest and moderate hyperkalemia.
Topics: Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Biphenyl Compounds; Bradycardia; Depression, C | 2006 |
Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; | 2002 |